We are live on !
Find out more
Longaeva Partners Portfolio holdings
AUM
$4.58B
Turnover
75.17%
1-Year Est. Return
43.91%
This Fund
S&P 500
This Quarter Est. Return
+20.82%
1 Year Est. Return
+43.91%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.58B
AUM Growth
+$1.88B
(+69%)
Cap. Flow
+$1.03B
Cap. Flow % of AUM
Cap. Flow %
22.6%
Top 10 Holdings %
Top 10 Hldgs %
29.9%
Holding
435
New
231
Increased
47
Reduced
58
Closed
96
Avg Time Held
Equity + Options
0.1
years
Top 10 Avg Time Held
Equity + Options
0
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.1
years
Top 10 Avg Time Held Equity only
0.1
years
Top 20 Avg Time Held Equity only
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$101M |
| 2 |
JPMorgan Chase
JPM
|
+$79.2M |
| 3 |
Moody's
MCO
|
+$58.8M |
| 4 |
Fifth Third Bancorp
FITB
|
+$58.5M |
| 5 |
LPL Financial
LPLA
|
+$56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PNC Financial Services
PNC
|
+$68M |
| 2 |
ACM Research
ACMR
|
+$48.8M |
| 3 |
Citizens Financial Group
CFG
|
+$47.1M |
| 4 |
Vishay Intertechnology
VSH
|
+$46.3M |
| 5 |
Goldman Sachs
GS
|
+$44.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.82% |
| 2 | Financials | 20.39% |
| 3 | Healthcare | 17.29% |
| 4 | Industrials | 14.57% |
| 5 | Technology | 7.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
Entrada Therapeutics
TRDA
$184M
| $1.44M | 0.03% |
195,237
-9,741
| -5% | -$93.4K |
2026 Q1
1 quarter
|
|
277
Howmet Aerospace
HWM
$86B
| $1.43M | 0.03% |
+5,321
| New | +$1.37M |
2026 Q2
0 quarters
|
|
278
Knight Transportation
KNX
$10B
| $1.41M | 0.03% |
18,134
+6,806
| +60% | +$472K |
2026 Q1
1 quarter
|
|
279
Ultragenyx Pharmaceutical
RARE
$1.67B
| $1.38M | 0.03% |
41,347
-186,760
| -82% | -$4.64M |
2026 Q1
1 quarter
|
|
280
Frontier Group Holdings
ULCC
$1.92B
| $1.38M | 0.03% |
+174,302
| New | +$899K |
2026 Q2
0 quarters
|
|
281
Willdan Group
WLDN
$1.05B
| $1.29M | 0.03% |
+16,307
| New | +$1.39M |
2026 Q2
0 quarters
|
|
282
C.H. Robinson
CHRW
$15B
| $1.26M | 0.03% |
+6,674
| New | +$1.19M |
2026 Q2
0 quarters
|
|
283
Tapestry
TPR
$26.7B
| $1.25M | 0.03% |
+8,513
| New | +$1.22M |
2026 Q2
0 quarters
|
|
284
TKO Group
TKO
$14.5B
| $1.22M | 0.03% |
+6,074
| New | +$1.18M |
2026 Q2
0 quarters
|
|
285
Snowflake
SNOW
$103B
| $1.21M | 0.03% |
+4,765
| New | +$877K |
2026 Q2
0 quarters
|
|
286
Neptune Insurance Holdings
NP
$3.89B
| $1.2M | 0.03% |
+38,095
| New | +$1.03M |
2026 Q2
0 quarters
|
|
287
Cullinan Oncology
CGEM
$755M
| $1.18M | 0.03% |
64,785
-118,906
| -65% | -$1.77M |
2026 Q1
1 quarter
|
|
288
Forgent Power Solutions
FPS
$6.2B
| $1.17M | 0.03% |
20,877
-97,534
| -82% | -$4.45M |
2026 Q1
1 quarter
|
|
289
Viking Holdings
VIK
$38.9B
| $1.15M | 0.03% |
+10,994
| New | +$951K |
2026 Q2
0 quarters
|
|
290
Palo Alto Networks
PANW
$271B
| $1.14M | 0.03% |
+3,356
| New | +$768K |
2026 Q2
0 quarters
|
|
291
Stevanato
STVN
$3.75B
| $1.12M | 0.02% |
+62,231
| New | +$1.05M |
2026 Q2
0 quarters
|
|
292
CrowdStrike
CRWD
$234B
| $1.09M | 0.02% |
+5,732
| New | +$814K |
2026 Q2
0 quarters
|
|
293
Cheniere Energy
LNG
$58.2B
| $1.09M | 0.02% |
+4,544
| New | +$1.13M |
2026 Q2
0 quarters
|
|
294
Pyxis Oncology
PYXS
$203M
| $1.06M | 0.02% |
353,582
-149,632
| -30% | -$286K |
2025 Q3
3 quarters
|
|
295
ASML
ASML
$583B
| $1.05M | 0.02% |
529
-19,124
| -97% | -$30.4M |
2026 Q1
1 quarter
|
|
296
Amphenol
APH
$199B
| $1.02M | 0.02% |
+11,530
| New | +$831K |
2026 Q2
0 quarters
|
|
297
DexCom
DXCM
$30.2B
| $1.01M | 0.02% |
14,973
-120,027
| -89% | -$8M |
2026 Q1
1 quarter
|
|
298
Matador Resources
MTDR
$6.18B
| $988K | 0.02% |
+19,850
| New | +$1.13M |
2026 Q2
0 quarters
|
|
299
Lincoln International
LCLN
$981M
| $895K | 0.02% |
+37,500
| New | +$885K |
2026 Q2
0 quarters
|
|
300
Arista Networks
ANET
$235B
| $895K | 0.02% |
+5,266
| New | +$827K |
2026 Q2
0 quarters
|
|
Similar funds
BWA
Longaeva Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Longaeva Partners held 435 positions worth $4.58B, up 69% from $2.7B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Longaeva Partners deployed $1.03B of net new capital in Q2 2026, opening 231 new positions and adding to 47 existing holdings. Its largest new stake was SpaceX: 596,829 shares worth $102M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was ACM Research, an estimated $48.8M trimmed.
- Longaeva Partners's largest Q2 2026 buy was SpaceX: 596,829 shares worth $102M.
- Longaeva Partners added most to Mettler-Toledo International in Q2 2026, an estimated $39.4M increase.
- Longaeva Partners's biggest Q2 2026 reduction was ACM Research, cutting an estimated $48.8M.
- Longaeva Partners fully exited PNC Financial Services in Q2 2026, selling an estimated $68M.
- Longaeva Partners's ten largest holdings make up 30% of its $4.58B portfolio in Q2 2026.
- Longaeva Partners opened 231 new positions and closed 96 in Q2 2026.
- Longaeva Partners's portfolio value rose 69% quarter-over-quarter to $4.58B.
Based on Longaeva Partners's 13F filing for Q2 2026, filed 14 Aug 2026.